Patent: 10,081,681
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 10,081,681
Title: | Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors |
Abstract: | Provided are methods for clinical treatment of tumors (e.g., advanced solid tumors) using an anti-LAG-3 antibody in combination with an anti-PD-1 antibody. |
Inventor(s): | Korman; Alan J. (Piedmont, CA), Lonberg; Nils (Woodside, CA), Fontana; David J. (Clyde Hill, WA), Gutierrez; Andres A. (Lawrenceville, NJ), Selby; Mark J. (San Francisco, CA), Lewis; Katherine E. (Lake Forest Park, WA) |
Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
Application Number: | 15/021,102 |
Patent Claims: | see list of patent claims |
Details for Patent 10,081,681
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bristol-myers Squibb Company | YERVOY | ipilimumab | Injection | 125377 | 03/25/2011 | See Plans and Pricing | 2033-09-20 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |